Advances in the treatment of children with acute promyelocytic leukemia
10.3760/cma.j.issn.2095-428X.2015.03.001
- VernacularTitle:儿童急性早幼粒细胞白血病的治疗进展
- Author:
Hui JIANG
;
Jiashi ZHU
- Publication Type:Journal Article
- Keywords:
Acute promyelocytic leukemia;
National Comprehensive Cancer Network of the United States;
Optimization of treatment;
Child
- From:
Chinese Journal of Applied Clinical Pediatrics
2015;30(3):161-164
- CountryChina
- Language:Chinese
-
Abstract:
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia,which is rare in children.The treatment of APL mainly includes anthracycline-based chemotherapy,all-trans retinoic acid,and arsenic trioxide,which allow for complete remission,improve the long time survival rate and reduce related toxicity as well.About the optimized treatment,quick breakthroughs have already reached,not only at home in the 80's at the end of the 90's,but also abroad,like National Comprehensive Cancer Network of the United States in 2006-2013.This review summarizes the progress in diagnosis and treatment of children with APL.
